Clinical Cancer Research

16 May 2008 | : *News*

A new issue of Clinical Cancer Research is available online:
15 May 2008; Vol. 14, No. 10

The below Table of Contents is available online at: http://clincancerres.aacrjournals.org/content/vol14/issue10/?etoc

——————————————————————————–
Molecular Pathways
——————————————————————————–

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer
Jeffrey A. Engelman and Pasi A. Jänne
Clin Cancer Res 2008;14 2895-2899
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2895

——————————————————————————–
Review
——————————————————————————–

Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
Jann N. Sarkaria, Gaspar J. Kitange, C. David James, Ruth Plummer, Hilary Calvert, Michael Weller, and Wolfgang Wick
Clin Cancer Res 2008;14 2900-2908
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2900

——————————————————————————–
Human Cancer Biology
——————————————————————————–

Helicobacter pylori Augments Growth of Gastric Cancers via the Lipopolysaccharide-Toll-like Receptor 4 Pathway whereas Its Lipopolysaccharide Attenuates Antitumor Activities of Human Mononuclear Cells
Kentaro Chochi, Takashi Ichikura, Manabu Kinoshita, Takashi Majima, Nariyoshi Shinomiya, Hironori Tsujimoto, Toshinobu Kawabata, Hidekazu Sugasawa, Satoshi Ono, Shuhji Seki, and Hidetaka Mochizuki
Clin Cancer Res 2008;14 2909-2917
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2909

Epigenetic Silencing of the Tetraspanin CD9 during Disease Progression in Multiple Myeloma Cells and Correlation with Survival
Elke De Bruyne, Tomas Jan Bos, Kewal Asosingh, Isabelle Vande Broek, Eline Menu, Els Van Valckenborgh, Peter Atadja, Valérie Coiteux, Xavier Leleu, Kris Thielemans, Ben Van Camp, Karin Vanderkerken, and Ivan Van Riet
Clin Cancer Res 2008;14 2918-2926
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2918

Detection of Copy Number Alterations in Metastatic Melanoma by a DNA Fluorescence In situ Hybridization Probe Panel and Array Comparative Genomic Hybridization: A Southwest Oncology Group Study (S9431)
Stephen R. Moore, Diane L. Persons, Jeffrey A. Sosman, Dolores Bobadilla, Victoria Bedell, David D. Smith, Sandra R. Wolman, Ralph J. Tuthill, Jim Moon, Vernon K. Sondak, and Marilyn L. Slovak
Clin Cancer Res 2008;14 2927-2935
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2927

Divergent Effects of Castration on Prostate Cancer in TRAMP Mice: Possible Implications for Therapy
Yao Tang, Linbo Wang, Olga Goloubeva, Mohammad Afnan Khan, Bin Zhang, and Arif Hussain
Clin Cancer Res 2008;14 2936-2943
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2936

Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer
Gert G. Van den Eynden, Marcel Smid, Steven J. Van Laere, Cecile G. Colpaert, Ilse Van der Auwera, Trinh Xuan Bich, Peter van Dam, Michael A. den Bakker, Luc Y. Dirix, Eric A. Van Marck, Peter B. Vermeulen, and John A. Foekens
Clin Cancer Res 2008;14 2944-2952
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2944

Loss of Heterozygosity at the BRCA2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline BRCA2 Mutation
Amber J. Willems, Sarah-Jane Dawson, Hema Samaratunga, Alessandro De Luca, Yoland C. Antill, John L. Hopper, Heather J. Thorne, and and kConFab Investigators
Clin Cancer Res 2008;14 2953-2961
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2953

Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
Pingyu Zhang, Yanwen Yang, Patrick A. Zweidler-McKay, and Dennis P.M. Hughes
Clin Cancer Res 2008;14 2962-2969
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2962

——————————————————————————–
Imaging, Diagnosis, Prognosis
——————————————————————————–

Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine
Andreas K. Buck, Ken Herrmann, Christian Meyer zum Büschenfelde, Malik E. Juweid, Mark Bischoff, Gerhard Glatting, Gregor Weirich, Peter Möller, Hans-Jürgen Wester, Klemens Scheidhauer, Tobias Dechow, Christian Peschel, Markus Schwaiger, and Sven N. Reske
Clin Cancer Res 2008;14 2970-2977
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2970

Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome Analysis
Sreekanth P. Reddy, Ramona Britto, Katyayni Vinnakota, Hebbar Aparna, Hari Kishore Sreepathi, Balaram Thota, Arpana Kumari, B.M. Shilpa, M. Vrinda, Srikantha Umesh, Cini Samuel, Mitesh Shetty, Ashwani Tandon, Paritosh Pandey, Sridevi Hegde, A.S. Hegde, Anandh Balasubramaniam, B.A. Chandramouli, Vani Santosh, Paturu Kondaiah, Kumaravel Somasundaram, and M.R. Satyanarayana Rao
Clin Cancer Res 2008;14 2978-2987
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2978

Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
Ben S. Wittner, Dennis C. Sgroi, Paula D. Ryan, Tako J. Bruinsma, Annuska M. Glas, Anitha Male, Sonika Dahiya, Karleen Habin, Rene Bernards, Daniel A. Haber, Laura J. Van’t Veer, and Sridhar Ramaswamy
Clin Cancer Res 2008;14 2988-2993
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2988

Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome
Devasis Chatterjee, Edmond Sabo, Rosemarie Tavares, and Murray B. Resnick
Clin Cancer Res 2008;14 2994-3001
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/2994

Translocations Involving the Immunoglobulin Heavy Chain Gene Locus Predict Better Survival in Gastric Diffuse Large B-Cell Lymphoma
Shotaro Nakamura, Hongtao Ye, Chris M. Bacon, Alison Goatly, Hongxiang Liu, Lucy Kerr, Alison H. Banham, Berthold Streubel, Takashi Yao, Masazumi Tsuneyoshi, Antonella Savio, Morishige Takeshita, Peggy Dartigues, Agnès Ruskoné-Fourmestraux, Takayuki Matsumoto, Mitsuo Iida, and Ming-Qing Du
Clin Cancer Res 2008;14 3002-3010
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3002

Bcl-B Expression in Human Epithelial and Nonepithelial Malignancies
Maryla Krajewska, Shinichi Kitada, Jane N. Winter, Daina Variakojis, Alan Lichtenstein, Dayong Zhai, Michael Cuddy, Xianshu Huang, Frederic Luciano, Cheryl H. Baker, Hoguen Kim, Eunah Shin, Susan Kennedy, Allen H. Olson, Andrzej Badzio, Jacek Jassem, Ivo Meinhold-Heerlein, Michael J. Duffy, Aaron D. Schimmer, Ming Tsao, Ewan Brown, Anne Sawyers, Michael Andreeff, Dan Mercola, Stan Krajewski, and John C. Reed
Clin Cancer Res 2008;14 3011-3021
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3011

Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer
Junichi Matsubara, Yasuhide Yamada, Yoshinori Hirashima, Daisuke Takahari, Natsuko T. Okita, Ken Kato, Tetsuya Hamaguchi, Kuniaki Shirao, Yasuhiro Shimada, and Tadakazu Shimoda
Clin Cancer Res 2008;14 3022-3029
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3022

Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
Timothy J. Duncan, Ahmad Al-Attar, Phil Rolland, Ian V. Scott, Suha Deen, David T.Y. Liu, Ian Spendlove, and Lindy G. Durrant
Clin Cancer Res 2008;14 3030-3035
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3030

N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
Ronnie C. Mease, Crystal L. Dusich, Catherine A. Foss, Hayden T. Ravert, Robert F. Dannals, Jurgen Seidel, Andrew Prideaux, James J. Fox, George Sgouros, Alan P. Kozikowski, and Martin G. Pomper
Clin Cancer Res 2008;14 3036-3043
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3036

——————————————————————————–
Cancer Therapy: Clinical
——————————————————————————–

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
Raanan Berger, Rinat Rotem-Yehudar, Gideon Slama, Shimon Landes, Abraham Kneller, Merav Leiba, Maya Koren-Michowitz, Avichai Shimoni, and Arnon Nagler
Clin Cancer Res 2008;14 3044-3051
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3044

Clinical and Biological Effects of Neoadjuvant Sargramostim and Thalidomide in Patients with Locally Advanced Prostate Carcinoma
Jorge A. Garcia, Eric A. Klein, Cristina Magi-Galluzzi, Paul Elson, Pierre Triozzi, and Robert Dreicer
Clin Cancer Res 2008;14 3052-3059
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3052

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
James L. Gulley, Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole, Cinzia Remondo, Vittore Cereda, Jacquin L. Jones, Mary P. Pazdur, Jack P. Higgins, James W. Hodge, Seth M. Steinberg, Herbert Kotz, William L. Dahut, and Jeffrey Schlom
Clin Cancer Res 2008;14 3060-3069
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3060

Tamoxifen and Aromatase Inhibitors Differentially Affect Vascular Endothelial Growth Factor and Endostatin Levels in Women with Breast Cancer
Chris E. Holmes, Joe C. Huang, Thomas R. Pace, Alan B. Howard, and Hyman B. Muss
Clin Cancer Res 2008;14 3070-3076
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3070

Phase II Trial of Tipifarnib as Maintenance Therapy in First Complete Remission in Adults with Acute Myelogenous Leukemia and Poor-Risk Features
Judith E. Karp, B. Douglas Smith, Ivana Gojo, Jeffrey E. Lancet, Jacqueline Greer, Maureen Klein, Larry Morris, Mark J. Levis, Steven D. Gore, John J. Wright, and Elizabeth Garrett-Mayer
Clin Cancer Res 2008;14 3077-3082
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3077

Efficacy of Gemcitabine in Patients with Non–Small Cell Lung Cancer According to Promoter Polymorphisms of the Ribonucleotide Reductase M1 Gene
Soo-Ok Kim, Ju-Yeon Jeong, Mi-Ran Kim, Hyun-Ju Cho, Jin-Yung Ju, Yong-Soo Kwon, In-Jae Oh, Kyu-Sik Kim, Yu-Il Kim, Sung-Chul Lim, and Young-Chul Kim
Clin Cancer Res 2008;14 3083-3088
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3083

Phase I Study and Preliminary Pharmacology of the Novel Innate Immune Modulator rBBX-01 in Gynecologic Cancers
Janet S. Rader, Charles F. Aylsworth, David A. Juckett, David G. Mutch, Matthew A. Powell, Lynne Lippmann, and Nikolay V. Dimitrov
Clin Cancer Res 2008;14 3089-3097
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3089

Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
Steven De Vleeschouwer, Steffen Fieuws, Stefan Rutkowski, Frank Van Calenbergh, Johannes Van Loon, Jan Goffin, Raf Sciot, Guido Wilms, Philippe Demaerel, Monika Warmuth-Metz, Niels Soerensen, Johannes E.A. Wolff, Sabine Wagner, Eckhart Kaempgen, and Stefaan W. Van Gool
Clin Cancer Res 2008;14 3098-3104
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3098

Phase I Clinical and Pharmacokinetic Study of Plitidepsin as a 1-Hour Weekly Intravenous Infusion in Patients with Advanced Solid Tumors
Miguel A. Izquierdo, Angela Bowman, Margarita García, Duncan Jodrell, Marisa Martinez, Beatriz Pardo, Javier Gómez, José A. López-Martin, José Jimeno, José R. Germá, and John F. Smyth
Clin Cancer Res 2008;14 3105-3112
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3105

——————————————————————————–
Cancer Therapy: Preclinical
——————————————————————————–

Evaluation of the In vitro and In vivo Antitumor Activity of Histone Deacetylase Inhibitors for the Therapy of Retinoblastoma
Clifton Lee Dalgard, Kurtis R. Van Quill, and Joan M. O’Brien
Clin Cancer Res 2008;14 3113-3123
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3113

Inhibition of Vascular Endothelial Growth Factor-A Signaling Induces Hypertension: Examining the Effect of Cediranib (Recentin; AZD2171) Treatment on Blood Pressure in Rat and the Use of Concomitant Antihypertensive Therapy
Jon O. Curwen, Helen L. Musgrove, Jane Kendrew, Graham H.P. Richmond, Donald J. Ogilvie, and Stephen R. Wedge
Clin Cancer Res 2008;14 3124-3131
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3124

Histone Deacetylase Inhibition and Blockade of the Glycolytic Pathway Synergistically Induce Glioblastoma Cell Death
Vivian Egler, Serdar Korur, Mike Failly, Jean-Louis Boulay, Roland Imber, Maria M. Lino, and Adrian Merlo
Clin Cancer Res 2008;14 3132-3140
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3132

Interaction of Imatinib with Human Organic Ion Carriers
Shuiying Hu, Ryan M. Franke, Kelly K. Filipski, Chaoxin Hu, Shelley J. Orwick, Ernst A. de Bruijn, Herman Burger, Sharyn D. Baker, and Alex Sparreboom
Clin Cancer Res 2008;14 3141-3148
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3141

A BTB/POZ Gene, NAC-1, a Tumor Recurrence–Associated Gene, as a Potential Target for Taxol Resistance in Ovarian Cancer
Masako Ishibashi, Kentaro Nakayama, Shamima Yeasmin, Atsuko Katagiri, Kouji Iida, Naomi Nakayama, Manabu Fukumoto, and Kohji Miyazaki
Clin Cancer Res 2008;14 3149-3155
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3149

Homeostatic Proliferation Plus Regulatory T-Cell Depletion Promotes Potent Rejection of B16 Melanoma
Justin Kline, Ian E. Brown, Yuan-Yuan Zha, Christian Blank, John Strickler, Harald Wouters, Long Zhang, and Thomas F. Gajewski
Clin Cancer Res 2008;14 3156-3167
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3156

Aspirin Sensitizes Cancer Cells to TRAIL–Induced Apoptosis by Reducing Survivin Levels
Meiling Lu, Anne Strohecker, Feng Chen, Toni Kwan, Joshua Bosman, V. Craig Jordan, and Vincent L. Cryns
Clin Cancer Res 2008;14 3168-3176
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3168

Chemopreventive Efficacy of Inositol Hexaphosphate against Prostate Tumor Growth and Progression in TRAMP Mice
Komal Raina, Subapriya Rajamanickam, Rana P. Singh, and Rajesh Agarwal
Clin Cancer Res 2008;14 3177-3184
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3177

Pretreatment with Cisplatin Enhances E7-Specific CD8+ T-Cell–Mediated Antitumor Immunity Induced by DNA Vaccination
Chih-Wen Tseng, Chien-Fu Hung, Ronald D. Alvarez, Cornelia Trimble, Warner K. Huh, Daejin Kim, Chi-Mu Chuang, Cheng-Tao Lin, Ya-Chea Tsai, Liangmei He, Archana Monie, and T-C. Wu
Clin Cancer Res 2008;14 3185-3192
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3185

Modulation of Drug Resistance in Ovarian Adenocarcinoma by Enhancing Intracellular Ceramide Using Tamoxifen-Loaded Biodegradable Polymeric Nanoparticles
Harikrishna Devalapally, Zhenfeng Duan, Michael V. Seiden, and Mansoor M. Amiji
Clin Cancer Res 2008;14 3193-3203
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3193

Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors
Narasimhan P. Agaram, Michael P. Laquaglia, Berrin Ustun, Tianhua Guo, Grace C. Wong, Nicholas D. Socci, Robert G. Maki, Ronald P. DeMatteo, Peter Besmer, and Cristina R. Antonescu
Clin Cancer Res 2008;14 3204-3215
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3204

——————————————————————————–
Cancer Prevention and Susceptibility
——————————————————————————–

A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and Outcome
Michael Lanuti, Geoffrey Liu, Jonathan M. Goodwin, Rihong Zhai, Bryan C. Fuchs, Kofi Asomaning, Li Su, Norman S. Nishioka, Kenneth K. Tanabe, and David C. Christiani
Clin Cancer Res 2008;14 3216-3222
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3216

VDR and SRD5A2 Polymorphisms Combine to Increase Risk for Prostate Cancer in Both Non–Hispanic White and Hispanic White Men
Kathleen C. Torkko, Adrie van Bokhoven, Phoung Mai, Joke Beuten, Ivana Balic, Tim E. Byers, John E. Hokanson, Jill M. Norris, Anna E. Barón, M. Scott Lucia, Ian M. Thompson, and Robin J. Leach
Clin Cancer Res 2008;14 3223-3229
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3223

Functional Variants in Cell Death Pathway Genes and Risk of Pancreatic Cancer
Ming Yang, Tong Sun, Li Wang, Dianke Yu, Xuemei Zhang, Xiaoping Miao, Junniao Liu, Dan Zhao, Hui Li, Wen Tan, and Dongxin Lin
Clin Cancer Res 2008;14 3230-3236
http://clincancerres.aacrjournals.org/cgi/content/abstract/14/10/3230

American Cancer Society News

16 May 2008 | : *News*

spacer

Action Alerts Stationary Top


Fighting Back At A Traffic Light

The traffic light turned red. And suddenly two Ohioans jumped out of their car, ran to the front door of the ACS CAN Fight Back Express and asked to sign the bus.

That incredible story is just one example of the passion that is helping launch a nationwide grassroots movement to make cancer issues a national priority. And ACS CAN is prepared to capture the signatures, stories and passion of all Americans with the Fight Back Express national bus tour.

It turns out these cancer advocates had seen a story about the bus on their local evening news and made the quick decision to be part of this historic grassroots movement. When they realized they missed the bus event at their local mall, they hit the streets to track down the bus and get their signature on it.

Cleveland FBE LaunchAlready the ACS CAN Fight Back Express bus has been through Ohio and Pennsylvania and the excitement continues to build. Read our Bus Blog to read about and comment on more great stories. What’s the Fight Back Express? Visit acscan.org/bus to learn more, find out when the bus is coming to your community and learn how you can help keep the bus on the road.

ACS CAN Premium Content
A special feature article only for members of ACS CAN
ACS CAN Releases New Poll On Cancer Research Funding

Not a member of ACS CAN?Click here to join and start enjoying great member benefits.

State Legislature Update

ACS CAN and American Cancer Society staff and volunteers are partnering together on legislative campaigns on the state and local level. Here is an update on our recent legislative successes. Kentucky Covers Colon Cancer
Kentucky Governor Steve Beshear and the legislature continued their efforts to prevent colon cancer by signing a statewide colon cancer screening and treatment program targeting uninsured Kentuckians between ages 50-64. The program is modeled after the state Women’s Cancer Screening Program.

Ohio Requires Insurance Coverage for Clinical Trials
The Ohio legislature passed and the Governor is expected to sign legislation that guarantees coverage of all routine medical care costs for those enrolled in clinical trials.

Pennsylvania Bill Preserves Unused Cancer Medication
In a victory for Pennsylvania cancer patients, Governor Rendell signed the Cancer Drug Repository Bill, which allows people to return their unused cancer medications to select pharmacies where they will be repackaged and sold at a reduced cost to cancer patients who need them.

Florida Bill that Favored Tobacco Industry is Defeated
A bill intended to change the way spit tobacco and “other tobacco products” are taxed was defeated. The proposal would have changed the tax law in favor of tobacco companies and reduced the impact the tax has on tobacco prevention.

Arizona Scores Tobacco Cessation Coverage
Two years of staff and volunteer efforts finally paid off when Governor Napolitano signed legislation that allows Arizona’s Medicaid program to cover tobacco cessation medications such as nicotine replacement products.

Find out what exciting things are going on in your state.

Web Bug from http://action.acscan.org/site/PixelServer?j=EKaoYoDSqAKIMfXfMTdMwA..

Dana-Farber Cancer Institute News

12 May 2008 | : *News*


This Month
60 years strong
May 22, 2008, marks the 60th anniversary of the founding of the Jimmy Fund. On this day in 1948, Ralph Edwards interviewed a young cancer patient named “Jimmy” on the national “Truth or Consequences” radio show and the Jimmy Fund was born. Learn more
Listen to the 1948 broadcast
May Spotlight:
Sun Safety
Discover sun safety tips, learn about melanoma research, watch videos on skin cancer prevention and ask our staff about avoiding UV overexposure.
Explore Spotlight
Monthly health quiz
What is the most common risk factor for prostate cancer? Take the quiz
Nutrition tip and recipe of the month
Studies of whole grains and cancer risk have found that people who eat large amounts of whole grains have a 34 percent reduced risk of cancer compared to those who eat small amounts. Try these Asparagus Chicken Crepes, made with whole wheat flour.
Get the recipe
Ask the Nutritionist
Online Stores
Show your pride for Dana-Farber by sporting an item from our online stores. Choose from dozens of products with the Dana-Farber, Jimmy Fund, or individual event logo.
Browse online stores
How to Help
Surprise Party
Join the Friends of Dana-Farber at the Wang Theatre for the launch of Surprise Party. Funds raised will benefit innovative, groundbreaking research, clinical trials, and community outreach programs such as nursing, social services, and pastoral care. Learn more
Greeting Cards
In lieu of a gift, send your friends, family, clients or business associates a personalized greeting card. For a minimum contribution of $25, our cards come in a variety of styles and are mailed within one business day.
View greeting cards
Mission Possible Campaign
For 60 years, it has been our vision to eradicate cancer and the fear it engenders. Support Dana-Farber’s $1 billion campaign to conquer cancer. Mission Possible Campaign
Make a gift
Your gift to Dana-Farber helps us find cures for cancer and related diseases and makes a difference in the lives of those living with cancer. Make a gift
Resources
Feedback
We are very interested in your thoughts about our newsletter. Please send us an e-mail.
For more information about our programs and services, visit www.dana-farber.org or www.jimmyfund.org.
Dedicated to Discovery. Committed to Care.
Featured Story
MAY 2008
Photomicrograph of a cross-cut from human palm skin, magnified 36 times
Report describes first targeted therapy to produce remission of metastatic melanoma
In a demonstration that even some of the most hard-to-treat tumors may one day succumb to therapies aimed at molecular “weak points,” researchers at Dana-Farber report the first instance in which metastatic melanoma has been driven into remission by a targeted therapy. Read more
News
Blue Cross Blue Shield of Massachusetts Health Care Excellence Awards

Blue Cross Blue Shield of Massachusetts honors Dana-Farber with second annual Health Care Excellence Award

A panel of health experts cited Dana-Farber’s patient- and family-centered care model as a best practice for engaging patients and families in every aspect of care. Read more

Dr. Benz testifies before the Senate Committee on Health, Education, Labor, and Pensions

Dr. Edward J. Benz Jr. testifies at Senate hearing on war on cancer

As part of a U.S. Senate Committee hearing on federal priorities for the fight against cancer, Dr. Benz urged legislators to view cancer research through the widest possible prism. Read more

Lance Armstrong visits with Dana-Farber patient

Lance Armstrong lifts spirits during Dana-Farber visit

When famed cyclist Lance Armstrong visited Dana-Farber on April 18, he brightened the day of every patient, survivor, and staff member who shook his hand, posed for a photo, or thanked him for his work on behalf of the cancer cause. Read more | View the video | Photo gallery

Kornelia Polyack, MD

Cells lining milk ducts hold key to spread of common form of breast cancer, study finds

When a form of breast cancer that begins in the milk ducts invades neighboring tissue, the cause lies not in the tumor but in a group of abnormal surrounding cells, according to a new study led by Dana-Farber researchers. Read more

the jersey pulled from Yankee Stadium

“Yankee curse” jersey raises $175,100

After a week-long online auction, the David Ortiz jersey chipped from the cement of the new Yankee Stadium raised $175,100 for the Jimmy Fund. The proceeds will benefit adult and pediatric cancer care and research at Dana-Farber. Read more | View the video

Laser scan of a brain tumor shows areas (in red) where a gene called p18INK4C is overactive.

New data-handling technique finds genes to be team players in restraining brain cancer cell growth

The search for cancer genes is increasingly a matter of molecular “To Tell the Truth,” as scientists seek to distinguish genes actually involved in the disease from those that are imposters. Read more

Jimmy Fund Clinic patient Molly O'Neill tries on David Ortiz's World Series ring

Patient helps Red Sox, Jimmy Fund “ring in” 55 years together

When David Ortiz of the Red Sox proudly showed off his new 2008 World Series ring during Opening Day ceremonies at Fenway Park, a gaggle of photographers jockeyed to get a closer look at Big Papi’s bling. Eleven-year-old fan Molly O’Neill, however, had already seen it up close, and even got to try it on before Ortiz. Read more

Matt Shea

Survivor Story: College student/cancer patient inhabits two worlds

As a sarcoma patient, Matt Shea found the Jimmy Fund Clinic to be a warm, welcoming place, which is one of the reasons why the college senior spent his Fridays there as a volunteer. Read his story

Save the Date
hands being held
Thursday, May 15, 2008
Melanoma Support Group
DFCI, Smith 240 Conference Room
5:30 - 7 p.m.
This support group is for patients being treated for melanoma. To register, contact Mary Lou Hackett, LICSW, at (617) 632-4134
Jimmy Fund Scooper Bowl logo
Tuesday through Thursday, June 10-12, 2008
Jimmy Fund Scooper Bowl®
The Jimmy Fund Scooper Bowl is widely regarded as Boston’s official kick-off to summer. Gear up for this delicious event by purchasing group tickets or a Scooper Pass, which allows you to enter three times.
Purchase tickets
Living Proof logo
June 16-20, 2008
National Cancer Survivors’ Week
Living Proof: Celebrating Survivorship Workshops
Dana-Farber and the Perini Family Survivors’ Center will recognize National Cancer Survivors’ Week during the third week of June. The event features more than a dozen workshops on topics such as health insurance, finances, complementary therapies, nutrition, spirituality and advocacy. For more information or to register, please call (800) 883-6012.
Learn more and view workshop descriptions
Steve Carell and Anne Hathaway in Get Smart
Thursday, June 19, 2008
A Premiere Cause: Get Smart
Join Steve Carell for a special screening of his new film “Get Smart” to benefit the Zachary Carson Brain Tumor Fund at Dana-Farber. Learn more

For more information

To view all of our upcoming seminars, workshops, and fundraising events, go to our Event Calendar. Learn more

© Dana-Farber Cancer Institute | 44 Binney Street | Boston, MA 02115 | www.dana-farber.org

Beyond A Cure

12 May 2008 | : *News*

Web Bug from http://www.drsusanlove.com/newsletter/images/spacer.gif
May 2008

A Message from Dr. Love
Happy MotherÂ’s Day
With Mother’s Day just around the corner, my thoughts go to my daughter who is now a sophomore in college. One of my favorite stories from when she was little was the time she asked me what I did when I went to work. She must have been around four. I told her, “I fix owies on ladies breasts.” She thought for a moment and then said, “Do you kiss their owies like you do mine so that theyÂ’ll get all better?” I wish it were that easy!

ThereÂ’s certainly something about being a mom that makes you want to make everything right. When I was a surgeon, I met woman after woman who would navigate through her diagnosis and treatment with the goal of never missing a carpool pick-up, a soccer game, or a childÂ’s musical performance. Time after time, these women refused to relinquish their role as “Mom” to this disease, or to allow it to invade their childrenÂ’s lives. I’m not sure many of them viewed this as a choice. I think they just thought that’s what a mother does. MORE>

Hot Topics
NBCCÂ’s Annual Advocacy Training Conference
Hundreds of grassroots advocates from the US and abroad were in Washington, DC, April 26 through April 29 for the National Breast Cancer Coalition FundÂ’s Annual Advocacy Training Conference.

The training conference included sessions on topics ranging from emerging therapies in breast cancer treatment and health care reform to how the legislative process works and effective advocacy. It ended with a formal lobby day, where advocates had the opportunity to speak with their representatives about the importance of breast cancer research and the need to insure that every person diagnosed with breast cancer has access to quality care.

You can learn more about NBCC and Advocacy Training on their conference blog. Read more.

Cause for Love
MotherÂ’s Day is May 11th!
Honor the Women You Love

Looking for just the right Mother’s Day gift? Consider a tribute gift to the Foundation. Your gift can be in honor or in memory of your own mother, stepmother, foster mom, or aunt. It could honor someone else’s mom. Or it could honor a young woman who will one day be a mom. Wouldn’t it be amazing if we could keep every little girl from ever having to worry about breast cancer? Doing so is within our reach. Honor a woman you know TODAY!

Another Great Gift for Mom!
boscia preservative-free skincare has a special Mother’s Day offer for Foundation supporters. Receive a free deluxe travel-size of their best-selling Purifying Cleansing Gel with any purchase when you enter the code “loveboscia” before check-out (offer ends 5/15/08). As always, 10% of the proceeds from your purchase of Rose Blotting Linens will be donated to the Foundation to support our research program. Visit www.boscia.net for more information.

First Annual Love Walk, May 18, 2008
Pacific Palisades, California

The Dr. Susan Love Research Foundation is proud to partner with the Pacific Palisades Junior WomenÂ’s Club, which will be hosting the First Annual Pacific Palisades Love Walk to benefit the Foundation. The 5K walk will journey through the beautiful Pacific Palisades, and is open to kids and adults.

STOMP OUT BREAST CANCER…JOIN THE LOVE WALK.

LEARN MORE AND REGISTER TODAY!

Research Update
Women Needed for Groundbreaking DCIS Study
The Foundation is looking for 30 Northern Californian women who have recently been diagnosed with ductal carcinoma in situ (DCIS) to take part in a groundbreaking new research project that involves injecting a small amount of a chemotherapy drug into the affected breast duct. Study participants will then have their DCIS surgery four to six weeks later. The breast tissue collected during the surgery will be carefully examined to see the effects of the drug on the DCIS. If the study successfully shows that the drug has an impact on the DCIS, it could lead to a nationwide clinical trial of intraductal therapy for DCIS.

This research project, which was funded by the California Breast Cancer Research Program, is being conducted in collaboration with Ellen Mahoney, MD, and the Humboldt Community Breast Heath Project. Research participants will need to travel to Eureka, Calif., for the treatment and the surgery. Please call Ashley Casano at (310) 230-1712 Ext. 32 or send her an email for more information.

© 2006-2008 Dr. Susan Love Research Foundation
All rights reserved

CancerWise Newsletter

08 May 2008 | : *News*, Announcements


May 2008

The new issue of CancerWise is now available online at www.cancerwise.org


  • Program Helps Young Cancer Patients
    Three young cancer patients give examples of how they received help with emotional, social, psychological and educational issues during treatment.

    Read More
  • Q&A: Services Young Cancer Patients Need
    Young cancer patients have physical, emotional, educational and social needs that need to be addressed during treatment. Describing resources is Martha Askins, Ph.D., director of the Child, Adolescent and Young Adult (CAYA) Outreach program at the Children’s Cancer Hospital at M. D. Anderson.
    Read More
  • MRI Emerges as Breast Cancer Tool
    MRI can find cancers not visible with mammography and ultrasound, as it did in the case of Mary Mujica, who has a strong family history of breast cancer. M. D. Anderson experts list eight scenarios in which MRI is recommended as a breast screening tool for women at high risk of breast cancer.
    Read More

CancerWise Articles


Forward to a Friend Feedback
If you think this publication would be helpful to friends or loved ones, pass on this e-mail. If they are interested in subscribing, they can click on the following link: Subscribe to CancerWise We are very interested in hearing your thoughts about CancerWise. Please use our feedback form to tell us what you think.
To learn moreabout The University of Texas M. D. Anderson Cancer Center, visit our website. If you have questions about the content in CancerWise or need assistance with this subscription, simply reply to this message.
(c)2007 The University of Texas M. D. Anderson Cancer Center
The material and content contained in CancerWise is for general health information only and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Users of CancerWise should not rely exclusively on information provided in CancerWise for their own health needs. All specific medical questions should be presented to your own health care provider.

Mother’s Day

07 May 2008 | : *News*, Announcements

American Cancer Society Give in Honor of the Women in Your Life
Forward to a Friend
Donate Now
Sign up for a free email mammogram reminder

Read Stories of Hope from breast cancer survivors

Watch a video about why you should get a mammogram

Learn how to help prevent cervical cancer

Find out which cancer screening tests are right for you

Participate in American Cancer Society events

Mother’s Day is a time to celebrate the special women who have touched our lives by showing appreciation for all they have done. Instead of giving flowers or candy, give hope for a future without cancer – there is no better gift.

This Mother’s Day, we invite you to honor and remember all the special women in your life by giving a donation to your American Cancer Society. When you make your gift, we will send an embossed personalized card, notifying them of your thoughtful contribution.

Thanks to our dedicated supporters, the Society has:

• Helped discover the use of mammography to screen for breast cancer
• Funded researchers who developed lifesaving breast cancer drugs Tamoxifen and Herceptin
• Supported the campaign that led to the widespread use of the Pap test to screen for cervical cancer


With your help, we can continue to make important advances in the fight against cancer. Thank you in advance for sharing hope for a future where cancer is no longer a life-threatening disease.
Give hope for a future without cancer and we’ll send the card.

Forward to a Friend | Donate Now | How Does Your Donation Help?
Legal & Privacy Information | State Fundraising Notices

For more information on the American Cancer Society, visit us at www.cancer.org.

This email was sent to christine@cancergrief.com.
If this email was an inconvenience to you, we apologize.

Unsubscribe: If you wish to no longer receive emails from the American Cancer Society,
please click here and your name will be removed from our list.

The American Cancer Society | 250 Williams Street NW | Atlanta, GA 30303-1002
Copyright 2000-2008 © American Cancer Society

Next Page »